glp-1 birth control agonist tirzepatide and oral contraceptives So-Called “Ozempic Babies” Raise Questions

Understanding whether these symptoms result from direct drug effects, rapid weight loss, or other factors is essential for patients and clinicians

Research indicates that gastroparesis may be more common in patients who take GLP-1 drugs like Ozempic than in people who take other weight loss drugs

First, because of the small number of studies meeting the inclusion criteria, only 5 reports were extracted and merged, which increased the uncertainty of the results

The cost depends on the patients insurance scheme, the brand of drug and possible payment programmes

GLP-1R activation promotes -cell proliferation and anti-apoptosis through the PI3K/Akt pathway (Table 1), contributing to an increase in -cell numbers (Liu et al., 2024)

Use of GLP-1 receptor agonists and occurrence of thyroid disorders: a meta-analysis of randomized controlled trials